eCite Digital Repository

Use of contraindicated drugs in patients with chronic liver disease: A therapeutic dilemma

Citation

Sistanizad, M and Peterson, GM, Use of contraindicated drugs in patients with chronic liver disease: A therapeutic dilemma, International Journal of Clinical Pharmacology and Therapeutics, 51, (1) pp. 1-4. ISSN 0946-1965 (2013) [Refereed Article]

Copyright Statement

Copyright 2013 Dustri-Verlag Dr Karl Feistle

DOI: doi:10.5414/CP201705

Abstract

Objective: To investigate the prevalence of prescribing of contraindicated drugs or those requiring caution, in hospital inpatients with chronic liver disease.

Methods: The medical records and drug charts of adult hospitalized patients, consecutively admitted with clinical documentation and biochemical evidence of chronic liver disease, were studied retrospectively. Comparison was made between the prescription details for each drug and the recommendations for use in patients with liver disease under the approved product information, which indicates drugs that could be hepatotoxic and those that could have markedly altered pharmacokinetics or pharmacodynamics in chronic liver disease.

Results: 49 eligible patients with both clinical documentation and confirmatory biochemical evidence of chronic liver disease were identified. Of these, 15 had received at least 1 contraindicated medication during hospitalization, with diazepam being the most common. 31 patients had received at least 1 drug which requires precaution in liver disease, with propranolol being the most common.

Conclusion: The use of contraindicated drugs or those requiring caution, occurred frequently in hospital patients with chronic liver disease. This could reflect the somewhat limited evidence base and the perhaps overly cautious nature of the official product information.

Item Details

Item Type:Refereed Article
Keywords:drug-induced, liver injury, hepatotoxicity, adverse drug reactions
Research Division:Medical and Health Sciences
Research Group:Pharmacology and Pharmaceutical Sciences
Research Field:Clinical Pharmacology and Therapeutics
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Clinical Health (Organs, Diseases and Abnormal Conditions) not elsewhere classified
Author:Peterson, GM (Professor Gregory Peterson)
ID Code:82323
Year Published:2013
Web of Science® Times Cited:1
Deposited By:Pharmacy
Deposited On:2013-01-24
Last Modified:2017-11-02
Downloads:0

Repository Staff Only: item control page